Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Clinical implications of repeated drug monitoring of imatinib in patients with metastatic gastrointestinal stromal tumour
Oslo Univ Hosp, Norwegian Radium Hosp, Dept Oncol, POB 4953, N-0424 Oslo, Norway.;Univ Oslo, Inst Clin Med, Oslo, Norway..
Oslo Univ Hosp, Norwegian Radium Hosp, Dept Oncol, POB 4953, N-0424 Oslo, Norway.;Univ Oslo, Inst Clin Med, Oslo, Norway..
Uppsala University, Disciplinary Domain of Science and Technology, Chemistry, Department of Chemistry - BMC, Analytical Chemistry.
Uppsala University, Disciplinary Domain of Science and Technology, Chemistry, Department of Chemistry - BMC, Analytical Chemistry.ORCID iD: 0000-0002-4597-041X
Show others and affiliations
2016 (English)In: Clinical Sarcoma Research, ISSN 2045-3329, Vol. 6, 21Article in journal (Refereed) Published
Abstract [en]

Background: Imatinib mesylate (IM) is the preferred treatment for the majority of patients with metastatic gastrointestinal stromal tumour (GIST). Low trough IM concentration (C-min) values have been associated with poor clinical outcomes in GIST patients. However, there are few studies of repeated measurements of IM levels, and therapeutic drug monitoring is not yet a part of routine clinical practice. This study was conducted to reveal clinical scenarios where plasma concentration measurement of IM trough level (Cmin) is advantageous. Methods: Patients with advanced GIST receiving IM were included from January 2011 to April 2015. Heparin plasma was collected at each follow-up visit. Ninety-six samples from 24 patients were selected for IM concentration measurement. Associations between IM plasma concentration and clinical variables were analyzed by Students't test, univariate and multivariate linear regression analyses. Results: The mean IM Cmin plasma concentrations for patients taking < 400, 400 and > 400 mg daily were 782, 1132 and 1665 ng/mL, respectively (p = 0.010). High IM C-min levels were correlated with age, low body surface area, low haemoglobin concentration, low creatinine clearance, absence of liver metastasis and no prior gastric resection in univariate analysis. In multivariate analysis age, gastric resection and liver metastasis were included in the final model. Eight patients had disease progression during the study, and mean IM levels were significantly lower at time of progression compared to the previous measurement for the same patients (770 and 1223 ng/mL, respectively; p = 0.020). Conclusions: Our results do not support repeated monitoring of IM levels on a routine basis in all patients. However, we have revealed clinical scenarios where drug measurement could be beneficial, such as for patients who have undergone gastric resection, suspicion of non-compliance, subjectively reported side effects, in elderly patients and at the time of disease progression.

Place, publisher, year, edition, pages
BIOMED CENTRAL LTD , 2016. Vol. 6, 21
Keyword [en]
Gastrointestinal stromal tumour, Drug monitoring, Imatinib, Plasma concentration
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:uu:diva-318622DOI: 10.1186/s13569-016-0062-2ISI: 000395289900001PubMedID: 27999655OAI: oai:DiVA.org:uu-318622DiVA: diva2:1084656
Funder
Swedish Research Council, 621-2011-4423 2015-4870
Available from: 2017-03-27 Created: 2017-03-27 Last updated: 2017-03-27Bibliographically approved

Open Access in DiVA

fulltext(959 kB)52 downloads
File information
File name FULLTEXT01.pdfFile size 959 kBChecksum SHA-512
6ebb0d036dc491a33cc5b8504ea2e8febda9625cc2e7b49c51a88eadae4299f351cda0c7f0bd3213daa92e52359a6929fda5b0e1f579ce8c20f1ff10c2999038
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Ubhayasekhera, KumariBergquist, Jonas
By organisation
Analytical Chemistry
In the same journal
Clinical Sarcoma Research
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
Total: 52 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 326 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf